The US represents the largest market for opioid addiction with 74.1% of 8MM sales, due to its larger addict population and ...

A study finds that the increased administration of naloxone by non-medical bystanders could be contributing to the 2023 decline in opioid overdose deaths. News outlets look at how that trend is ...

Due to the extreme mis-pricing I argue Indivior offers investors great risk/reward asymmetry. Find out why INDV stock is a ...

An effective treatment for opioid addiction is easier to get after the Biden administration changed rules. That's making a ...

Decreased regulations for the substance use disorder medication stand to provide patients with easier access to treatment ...

Adults with opioid use disorder who receive a higher daily dose of the opioid addiction treatment medication buprenorphine may have a lower risk of subsequent emergency department visits or use of ...

Popular MAT medicines, including Naltrexone, Antabuse, and Campral, are a gold standard in treating alcohol dependence. Methadone and Buprenorphine (along with Naltrexone in some cases) are often ...

Patients who received higher doses of buprenorphine, a common medication used to alleviate opioid withdrawal and cravings, were less likely to be hospitalized and less likely to discontinue ...

This systematic review looked at 26 studies of buprenorphine-precipitated withdrawal, including 5 randomized trials, all conducted between 2002 and 2023 and with a total sample size of 4,497 patients.

Just 44 percent of jails offer incarcerated people with opioid use disorder medications like methadone, buprenorphine or naltrexone to treat addiction, according to a new analysis of 1,028 jails ...

Medicines like methadone, naltrexone and buprenorphine can safely help inmates control cravings for opioids, easing them off the illicit drugs. But is such help routinely available? To find out, ...